- Home
- KURA vs REAX Comparison
KURA vs REAX Comparison
Compare KURA & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- REAX
- Stock Information
- Founded
- KURA 2014
- REAX 2018
- Country
- KURA United States
- REAX United States
- Employees
- KURA N/A
- REAX N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- REAX
- Sector
- KURA Health Care
- REAX
- Exchange
- KURA Nasdaq
- REAX Nasdaq
- Market Cap
- KURA 713.5M
- REAX 820.5M
- IPO Year
- KURA N/A
- REAX N/A
- Fundamental
- Price
- KURA $10.27
- REAX $3.72
- Analyst Decision
- KURA Strong Buy
- REAX Strong Buy
- Analyst Count
- KURA 13
- REAX 3
- Target Price
- KURA $25.00
- REAX $6.67
- AVG Volume (30 Days)
- KURA 1.9M
- REAX 1.6M
- Earning Date
- KURA 11-04-2025
- REAX 10-30-2025
- Dividend Yield
- KURA N/A
- REAX N/A
- EPS Growth
- KURA N/A
- REAX N/A
- EPS
- KURA N/A
- REAX N/A
- Revenue
- KURA $83,279,000.00
- REAX $1,813,907,000.00
- Revenue This Year
- KURA $68.63
- REAX $52.77
- Revenue Next Year
- KURA $141.59
- REAX $19.10
- P/E Ratio
- KURA N/A
- REAX N/A
- Revenue Growth
- KURA N/A
- REAX 65.60
- 52 Week Low
- KURA $5.41
- REAX $3.42
- 52 Week High
- KURA $19.73
- REAX $6.61
- Technical
- Relative Strength Index (RSI)
- KURA 57.06
- REAX 40.09
- Support Level
- KURA $10.18
- REAX $3.42
- Resistance Level
- KURA $11.06
- REAX $3.96
- Average True Range (ATR)
- KURA 0.62
- REAX 0.19
- MACD
- KURA -0.02
- REAX -0.01
- Stochastic Oscillator
- KURA 60.35
- REAX 45.45
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.